scholarly journals Pharmacokinetic study of a slow-release preparation of sodium valproate (KW-6066N). Multiple dose administration test and steady-state serum level profiles in patients with epilepsy.

1989 ◽  
Vol 7 (2) ◽  
pp. 152-159
Author(s):  
Akio Takeda ◽  
Hiroshi Hishida ◽  
Katsuo Amioka ◽  
Yasutaka Sakamoto ◽  
Shin-ichi Terao ◽  
...  
Keyword(s):  
Steady State ◽  
Serum Level ◽  
Multiple Dose ◽  
Slow Release ◽  
Dose Administration ◽  
Multiple Dose Administration ◽  
Release Preparation ◽  
Steady State Serum ◽  
Patients With Epilepsy ◽  
Slow Release Preparation

Study of adverse reactions to a once-weekly regimen of streptomycin plus a slow-release preparation of isoniazid in high dosage for six months

Tubercle ◽  
1976 ◽  
Vol 57 (2) ◽  
pp. 123-130 ◽  
Author(s):  
T. Santha ◽  
Wallace Fox ◽  
O. Nazareth ◽  
R. Prabhakar ◽  
S. Radhakrishna ◽  
...  
Keyword(s):  
Adverse Reactions ◽  
Slow Release ◽  
Release Preparation ◽  
Slow Release Preparation

scholarly journals Opicapone: a short lived and very long acting novel catechol-O-methyltransferase inhibitor following multiple dose administration in healthy subjects

2013 ◽  
Vol 76 (5) ◽  
pp. 763-775 ◽  
Author(s):  
José Francisco Rocha ◽  
Luis Almeida ◽  
Amílcar Falcão ◽  
P. Nuno Palma ◽  
Ana I. Loureiro ◽  
...  
Keyword(s):  
Healthy Subjects ◽  
Multiple Dose ◽  
Dose Administration ◽  
Multiple Dose Administration ◽  
Long Acting

Postscript: beta-blockers - the choice 1980, p 61 and 1981, p 20

1981 ◽  
Vol 19 (9) ◽  
pp. 36.2-36
Keyword(s):  
Slow Release ◽  
Beta Blockers ◽  
200Mg Tablet ◽  
Release Preparation ◽  
Slow Release Preparation

Metoprolol - A second slow-release preparation of metoprolol, Slow Lopresor (Geigy) has just been marketed. We had cited a study which indicated to us that one 200mg tablet of Slow Lopresor did not adequately block β-receptors for 24 hours (MJ Kendall et al, Eur J Clin Pharmacol 1980; 17: 87). The manufacturer has now shown us more recent evidence that one such tablet maintains some measurable β blockade over 24 hours, and is comparable with Betaloc SA.

Ventolin spandets (salbutamol)

1972 ◽  
Vol 10 (24) ◽  
pp. 94-95
Keyword(s):  
Single Dose ◽  
Slow Release ◽  
Salbutamol Sulphate ◽  
Release Preparation ◽  
Adrenergic Activity ◽  
Daily Dose ◽  
Slow Release Preparation

Salbutamol (Ventolin - A & H) is a sympathomimetic agent with mainly (β-adrenergic activity widely used as a bronchodilator. Ventolin Spandet has now been introduced as a slow-release preparation of oral salbutamol. The manufacturers make the specific claim that a single dose gives ‘predictable sustained relief of symptoms for up to 12 hours’, and recommend a daily dose of one. Spandet (salbutamol sulphate 8 mg) at bedtime and one after breakfast.

Sign in / Sign up

Export Citation Format

Share Document